Cresset Asset Management LLC Trims Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cresset Asset Management LLC decreased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 64.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,460 shares of the medical instruments supplier's stock after selling 20,567 shares during the period. Cresset Asset Management LLC's holdings in DENTSPLY SIRONA were worth $219,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. Crestline Management LP lifted its stake in DENTSPLY SIRONA by 152.4% in the fourth quarter. Crestline Management LP now owns 19,400 shares of the medical instruments supplier's stock valued at $368,000 after purchasing an additional 11,715 shares during the last quarter. Cubist Systematic Strategies LLC bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $8,048,000. Captrust Financial Advisors lifted its holdings in shares of DENTSPLY SIRONA by 39.0% in the fourth quarter. Captrust Financial Advisors now owns 23,548 shares of the medical instruments supplier's stock worth $447,000 after buying an additional 6,609 shares in the last quarter. Balyasny Asset Management L.P. purchased a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $576,000. Finally, Bastion Asset Management Inc. purchased a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $2,654,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.52% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Trading Up 0.1%

Shares of XRAY traded up $0.02 during mid-day trading on Thursday, reaching $15.85. The company's stock had a trading volume of 1,901,946 shares, compared to its average volume of 2,964,891. The stock has a market cap of $3.16 billion, a PE ratio of -7.66, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52 week low of $12.16 and a 52 week high of $28.44. The company's fifty day moving average price is $14.47 and its two-hundred day moving average price is $17.24.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was down 7.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.42 EPS. On average, analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.04%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

Analysts Set New Price Targets

XRAY has been the subject of several recent analyst reports. Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Mizuho dropped their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. Barrington Research lifted their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a research report on Monday, May 12th. Finally, Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus target price of $20.36.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.